Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.63 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.63 |
| ▸ | RECQL | P46063 | 1/20 | 0.56 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.55 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.50 |
| ▸ | PPARG | P37231 | 1/20 | 0.50 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | MME | P08473 | 2/20 | 0.45 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL309762 | 1.00 | CYP3A4 (0.63) | CYP3A4CYP2C9RECQLAKR1C3TBXAS1 | |
| SCHEMBL2918640 | 1.00 | CYP3A4 (0.63) | CYP3A4CYP2C9RECQLAKR1C3TBXAS1 | |
| SCHEMBL5173409 | 0.91 | TBXAS1 (0.58) | CYP3A4CYP2C9RECQLAKR1C3TBXAS1 | |
| Methacrylic Acid SCHEMBL10714804 | 0.91 | CYP3A4 (0.54) | CYP3A4CYP2C9RECQLAKR1C3TBXAS1 | |
| Oxirane SCHEMBL15646744 | 0.91 | CYP3A4 (0.54) | CYP3A4CYP2C9RECQLAKR1C3TBXAS1 | |
| SCHEMBL9061442 | 0.89 | TP53 (0.59) | CYP3A4CYP2C9RECQLAKR1C3TBXAS1 | |
| SCHEMBL15955486 | 0.88 | CYP3A4 (0.55) | CYP3A4CYP2C9RECQLAKR1C3TBXAS1 | |
| SCHEMBL15955485 | 0.88 | CYP3A4 (0.55) | CYP3A4CYP2C9RECQLAKR1C3TBXAS1 | |
| SCHEMBL5007835 | 0.88 | CYP3A4 (0.51) | CYP3A4CYP2C9RECQLAKR1C3TBXAS1 | |
| SCHEMBL30752458 | 0.86 | RECQL (0.70) | CYP3A4CYP2C9RECQLAKR1C3TBXAS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 724 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4426105-B1 | COCOA PLANT CELL CULTURE PROCESSING METHODS AND PRODUCTS OBTAINED BY THE SAME | ZHAW ZUERCHER HOCHSCHULE FUER ANGEWANDTE WSS (CH) | 2026-04-29 | — | — | EP | claimed |
| US-20250352444-A1 | Antimicrobial mixtures | SYMRISE AG (DE) | 2025-11-20 | — | — | US | claimed |
| EP-4609167-A1 | COMPOSITION AND METHOD FOR CLEARING BIOLOGICAL SAMPLES | Centre National de la Recherche Scientifique (FR) | 2025-09-03 | — | — | EP | claimed |
| EP-4525822-A1 | ANTIMICROBIAL MIXTURES | Symrise AG (DE) | 2025-03-26 | — | — | EP | claimed |
| EP-4255208-B1 | CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | VOYAGE FOODS INC (US) | 2024-12-25 | — | — | EP | claimed |
| EP-3930472-B1 | COFFEE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | VOYAGE FOODS INC (US) | 2024-09-11 | — | — | EP | claimed |
| WO-2024089224-A1 | COMPOSITION AND METHOD FOR CLEARING BIOLOGICAL SAMPLES | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2024-05-02 | — | — | WO | claimed |
| EP-3548890-B1 | MEANS AND METHODS FOR VISUALIZATION OF TISSUE STRUCTURES | GRETZ NORBERT (DE) | 2024-03-27 | — | — | EP | claimed |
| EP-4297900-A2 | CONTAINER FOR A SAMPLE AND METHOD FOR EXAMINING A SAMPLE WITH THE CONTAINER | Paul Marienfeld GmbH & Co. KG (DE) | 2024-01-03 | — | — | EP | claimed |
| US-20230383163-A1 | COOLING LIQUID COMPOSITION FOR ELECTRIC VEHICLE | KD FINECHEM CO., LTD. (KR) | 2023-11-30 | — | — | US | claimed |
| EP-0831870-A1 | USE OF ESSENTIAL OILS TO INCREASE BIOAVAILABILITY OF ORAL PHARMACEUTICAL COMPOUNDS | Avmax, Inc. (US) | 1998-04-01 | — | — | EP | claimed |
| US-5716928-A | ADMINISTERING DRUG CONCURRENTLY WITH ESSENTIAL OIL | AVMAX, INC. (US) | 1998-02-10 | — | — | US | claimed |
| WO-1997045568-A1 | ZINC PHOSPHATING WITH INTEGRATED SUBSEQUENT PASSIVATION | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1997-12-04 | — | — | WO | claimed |
| US-5665386-A | Use of essential oils to increase bioavailability of oral pharmaceutical compounds | AVMAX, INC. (US) | 1997-09-09 | — | — | US | claimed |
| US-5610249-A | FREE RADICAL CATALYST, ORGANIC PHOSPHORUS COMPOUND | KANSAI PAINT CO., LTD. (JP) | 1997-03-11 | — | — | US | claimed |
| WO-1996040192-A1 | USE OF ESSENTIAL OILS TO INCREASE BIOAVAILABILITY OF ORAL PHARMACEUTICAL COMPOUNDS | AVMAX, INC. (US) | 1996-12-19 | — | — | WO | claimed |
| EP-0319016-B1 | Treatment and after-treatment of metal with polyphenol compounds | HENKEL CORP (US) | 1994-06-22 | — | — | EP | claimed |
| EP-0319017-B1 | Treatment and after-treatment of metal with carbohydrate-modified polyphenol compounds | HENKEL CORP (US) | 1994-04-13 | — | — | EP | claimed |
| EP-0166542-A2 | Triterpenyl esters of organic acids, process for their production, and hypolipidemic agents composed of them | AMANO PHARMACEUTICAL CO., LTD. (JP) | 1986-01-02 | — | — | EP | claimed |
| EP-0009041-B1 | PROCESS FOR PREPARING AROMATIC AMIDE ANTIOXIDANTS | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1982-10-06 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250352444-A1 | Antimicrobial mixtures | LRBA, MGLL, TAS2R50 | CYP3A4 2500/4885CYP2C9 3901/4885RECQL 1921/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.